AstraZeneca Reverses As Beat And Raise Outweighs Drug Smuggling Claims
AstraZeneca beat third-quarter expectations and lifted its guidance Tuesday, and AstraZeneca stock rose despite a criminal probe in China. Continue reading View comments
- Supported exchanges /
- PINK /
- AZNCF.PINK
AstraZeneca PLC (AZNCF PINK) stock market data APIs
$131.38
0.02(0%)
as of November 26, 2024
Price chart is built with Anychart
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; BenevolentAI for drug discovery for systemic lupus erythematosus; Lunit for developing AI-Powered Digital Pathology Risk Assessment Tools for NSCLC; and Absci Corporation for AI-driven drug discovery against an oncology target. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
AstraZeneca PLC Financial Data Overview
| 131.36 | |
| 131.38 | |
| - | |
| 133.4 | |
| 130.75 | |
| 115.6083-175 | |
| 204 471 M | |
| 31.653 | |
| 1 550 M | |
| 51 206 M | |
| 0.9149 | |
| 0.0227 | |
| 0.18 |
Our easy-to-use no-coding solutions help you get the data effortlessly:
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
General: {
Code:
'AZNCF',
Type:
'Common Stock',
Name:
'AstraZeneca PLC',
Exchange:
'PINK',
CurrencyCode:
'USD',
CurrencyName:
'US Dollar',
CurrencySymbol:
'$',
CountryName:
'USA',
CountryISO:
'US',
OpenFigi:
'BBG000D3MHB4',
ISIN:
'GB0009895292',
CUSIP:
NULL,
CIK:
'901832',
EmployerIdNumber:
NULL,
FiscalYearEnd:
'December',
IPODate:
NULL,
InternationalDomestic:
NULL,
Sector:
'Healthcare',
Industry:
'Drug Manufacturers - General',
HomeCategory:
NULL,
IsDelisted:
false,
}
AstraZeneca PLC Fundamental Data is available in our Financial Data APIs
- Net Revenue 51 206 M
- EBITDA 18 391 M
- Earnings Per Share 4.15
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get AstraZeneca PLC Earnings via APIs
- Latest Release 2024-11-12
- EPS/Forecast NaN
Get AstraZeneca PLC End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Get AstraZeneca PLC latest news via APIs
China Has Detained a Senior AstraZeneca Executive
Leon Wang, executive vice president in charge of China and the broader Asian region, is being detained while the Chinese government is probing AstraZeneca employees. Continue reading View comments
Do you have any questions?
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
